Can biomarkers and AI transform traumatic brain injury care?
Discover how the HeadSMART II study is combining blood biomarkers, digital neurocognitive testing and AI to identify patients at risk of persistent TBI symptoms
Discover how the HeadSMART II study is combining blood biomarkers, digital neurocognitive testing and AI to identify patients at risk of persistent TBI symptoms
ECO rack GRIPTIPS® pipette tips are now translucent, making the recycled material more suitable for a wider range of new products
An analysis of data from more than 33,000 women found that breast density could partially explain the link between a higher body weight at age 20 and a lower chance of post-menopausal breast cancer
Dr. Vasiliki E. Kalodimou on women in STEM, global collaboration, and the next era of regenerative medicine
New Ancora assays for oncology produce precision results with MRD-grade sensitivity, delivering the full biological picture for every sample
Whether you're developing organoids, generating spheroids, evaluating organ-on-a-chip platforms, or implementing advanced 3D cell culture workflows, this free guide will help you compare leading 3D biology models, evaluate enabling technologies, and make informed decisions.
The collaboration combines Imagene’s AI-powered assay development and biomarker prediction capabilities with CellCarta’s global companion diagnostics (CDx) and laboratory infrastructure, supporting active programs with leading pharma partners
CLINICAL24 Ambassador Bamidele Farinre on workforce development, AI readiness, and creating opportunities for the next generation of laboratory professionals
Collaboration with AAV-specialist CDMO will support scalable production of EPY201 for focal refractory epilepsy affecting 10 million people